心内膜下受累作为肥厚型心肌病中与不良结局相关的被低估的晚期钆增强亚型
该单中心回顾性研究纳入497例经心脏磁共振证实存在晚期钆增强(LGE)的肥厚型心肌病患者,评估心内膜下受累LGE模式及右室插入点LGE的预后价值。中位随访57.9个月,66例(13.3%)发生复合终点事件。在LGE范围非广泛(<15%)的患者中,心内膜下受累LGE而非LGE范围与不良结局独立相关(HR: 2.12; P = 0.03)。
要点
- 心内膜下受累LGE定义为累及心内膜下且不符合冠状动脉分布区域的LGE,需排除缺血性心脏病所致。
- LGE范围非广泛(<15%)患者中,心内膜下受累LGE与复合终点独立相关(HR: 2.12; P = 0.03)。
- 右室插入点LGE与不良结局无显著关联。
核心结论
- 在LGE范围非广泛的肥厚型心肌病患者中,心内膜下受累LGE而非LGE范围与不良结局相关;鉴于广泛LGE的预后价值已被广泛认可,心内膜下受累作为一种被低估的LGE模式,可能改善非广泛LGE患者的风险分层。
研究设计与样本
- 单中心回顾性研究,纳入497例经心脏磁共振证实存在LGE的连续肥厚型心肌病患者,排除可能因缺血性心脏病导致心内膜下LGE的受试者;终点为心力衰竭相关事件、心律失常事件和卒中的复合终点。
关键影像表现/征象
- 497例患者中,心内膜下受累LGE见于184例(37.0%),右室插入点LGE见于414例(83.3%)。
- 广泛LGE(≥15%左心室质量)见于135例患者。
- 中位随访57.9个月期间,66例患者(13.3%)发生复合终点事件。
- 广泛LGE患者不良事件年发生率显著高于非广泛LGE患者(5.1% vs 1.9%每年;P < 0.001)。
- 样条分析显示LGE范围与不良结局HR之间的关联趋于非线性。
诊断标准与关键数值
- 心内膜下受累LGE定义为LGE累及心内膜下且不符合冠状动脉血管分布区域。
- 广泛LGE定义为LGE范围≥15%左心室质量。
- 广泛LGE患者中,校正左心室射血分数<50%、心房颤动和非持续性室性心动过速后,LGE范围与复合终点显著相关(HR: 1.05; P = 0.03)。
- 非广泛LGE(<15%)患者中,心内膜下受累LGE而非LGE范围与不良结局独立相关(HR: 2.12; P = 0.03)。
- 右室插入点LGE与不良结局无显著关联。
临床应用与阅片要点
- 在LGE范围非广泛(<15%左心室质量)的肥厚型心肌病患者中,识别心内膜下受累LGE模式可能有助于风险分层。
- 报告时应描述LGE是否累及心内膜下及是否符合冠状动脉分布,并注明右室插入点LGE情况。
- 广泛LGE(≥15%)患者中LGE范围与复合终点相关(HR: 1.05; P = 0.03),非广泛LGE患者中心内膜下受累LGE与不良结局独立相关(HR: 2.12; P = 0.03)。
局限性
- 本研究为单中心回顾性研究。
- 样条分析显示LGE范围与不良结局HR之间的关联趋于非线性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Late gadolinium enhancement (LGE) has been established as an independent predictor for adverse outcomes in hypertrophic cardiomyopathy (HCM). However, the prevalence and clinical significance of some LGE subtypes have not been well demonstrated.
OBJECTIVES: In this study, the authors sought to investigate the prognostic value of subendocardium-involved LGE pattern and location of right ventricle insertion points (RVIPs) with LGE in HCM patients.
METHODS: In this single-center retrospective study, 497 consecutive HCM patients with LGE confirmed by cardiac magnetic resonance (CMR) were included. Subendocardium-involved LGE was defined as LGE involving subendocardium not corresponding to a coronary vascular distribution. Subjects with ischemic heart disease that would contribute to subendocardial LGE were excluded. Endpoints included a composite of heart failure-related events, arrhythmic events, and stroke.
RESULTS: Of the 497 patients, subendocardium-involved LGE and RVIP LGE were observed in 184 (37.0%) and 414 (83.3%), respectively. Extensive LGE (≥15% of left ventricular mass) was detected in 135 patients. During a median follow-up of 57.9 months, 66 patients (13.3%) experienced composite endpoints. Patients with extensive LGE had a significantly higher annual incidence of adverse events (5.1% vs 1.9% per year; P < 0.001). However, spline analysis showed that the association between LGE extent and HRs for adverse outcomes tended to be nonlinear. The risk of composite endpoint increased with percentage increase in LGE extent in patients with extensive LGE, whereas a similar trend was not observed in patients with nonextensive LGE (<15%). In patients with extensive LGE, LGE extent significantly correlated with composite endpoints (HR: 1.05; P = 0.03) after adjusting for left ventricular ejection fraction <50%, atrial fibrillation, and nonsustained ventricular tachycardia, whereas in patients with nonextensive LGE, subendocardium-involved LGE rather than LGE extent was independently associated with adverse outcomes (HR: 2.12; P = 0.03). RVIP LGE was not significantly associated with poor outcomes.
CONCLUSIONS: In HCM patients with nonextensive LGE, the presence of subendocardium-involved LGE rather than LGE extent is associated with unfavorable outcomes. Given that the prognostic value of extensive LGE has been broadly recognized, subendocardial involvement as an underrecognized LGE pattern shows the potential to improve risk stratification in HCM patients with nonextensive LGE.
引用
- Yang, Zhao, Yang, et al. Subendocardial Involvement as an Underrecognized LGE Subtype Related to Adverse Outcomes in Hypertrophic Cardiomyopathy. JACC Cardiovasc Imaging. 2023. PMID: 37204388. doi:10.1016/j.jcmg.2023.03.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。